BioCardia, Inc.
General ticker "BCDA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.0M (TTM average)
BioCardia, Inc. does not follow the US Stock Market performance with the rate: -28.0%.
Estimated limits based on current volatility of 3.3%: low 1.38$, high 1.47$
Factors to consider:
- Total employees count: 20 as of 2023
- Top business risk factors: Operating losses and lack of profitability, Substantial financing needs, Third-party risks, Adverse events affecting product approval, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.09$, 3.79$]
- 2025-12-31 to 2026-12-31 estimated range: [1.12$, 3.75$]
Financial Metrics affecting the BCDA estimates:
- Positive: with PPE of -0.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -139.06 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 22.48 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BCDA quotes
Long-term BCDA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.35MM | $0.48MM | $0.06MM |
| Operating Expenses | $13.25MM | $12.12MM | $8.06MM |
| Operating Income | $-11.90MM | $-11.64MM | $-8.00MM |
| Non-Operating Income | $-0.01MM | $0.07MM | $0.05MM |
| R&D Expense | $8.83MM | $7.73MM | $4.39MM |
| Income(Loss) | $-11.91MM | $-11.57MM | $-7.95MM |
| Profit(Loss)* | $-11.91MM | $-11.57MM | $-7.95MM |
| Stockholders Equity | $4.89MM | $-1.60MM | $0.84MM |
| Assets | $9.79MM | $2.99MM | $3.72MM |
| Operating Cash Flow | $-10.56MM | $-9.97MM | $-8.03MM |
| Capital expenditure | $0.07MM | $0.01MM | $0.01MM |
| Investing Cash Flow | $-0.07MM | $-0.01MM | $-0.01MM |
| Financing Cash Flow | $5.12MM | $3.73MM | $9.30MM |
| Earnings Per Share** | $-10.08 | $-8.19 | $-2.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.